APGE
Price
$63.83
Change
-$0.08 (-0.13%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
4.37B
Intraday BUY SELL Signals
IRON
Price
$91.44
Change
+$1.70 (+1.89%)
Updated
Nov 19, 01:46 PM (EDT)
Capitalization
3.39B
128 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs IRON

Header iconAPGE vs IRON Comparison
Open Charts APGE vs IRONBanner chart's image
Apogee Therapeutics
Price$63.83
Change-$0.08 (-0.13%)
Volume$3.78K
Capitalization4.37B
Disc Medicine
Price$91.44
Change+$1.70 (+1.89%)
Volume$100
Capitalization3.39B
APGE vs IRON Comparison Chart in %
APGE
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APGE vs. IRON commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and IRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (APGE: $63.91 vs. IRON: $89.74)
Brand notoriety: APGE and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 55% vs. IRON: 48%
Market capitalization -- APGE: $4.37B vs. IRON: $3.39B
APGE [@Biotechnology] is valued at $4.37B. IRON’s [@Biotechnology] market capitalization is $3.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than IRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while IRON’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 4 bearish.
  • IRON’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, APGE is a better buy in the short-term than IRON.

Price Growth

APGE (@Biotechnology) experienced а +1.53% price change this week, while IRON (@Biotechnology) price change was +4.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

IRON is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($4.37B) has a higher market cap than IRON($3.39B). IRON (41.546) and APGE (41.082) have similar YTD gains . IRON has higher annual earnings (EBITDA): -142.42M vs. APGE (-270.1M). IRON has more cash in the bank: 650M vs. APGE (505M). APGE has less debt than IRON: APGE (10.8M) vs IRON (30.9M). APGE (0) and IRON (0) have equivalent revenues.
APGEIRONAPGE / IRON
Capitalization4.37B3.39B129%
EBITDA-270.1M-142.42M190%
Gain YTD41.08241.54699%
P/E RatioN/AN/A-
Revenue00-
Total Cash505M650M78%
Total Debt10.8M30.9M35%
TECHNICAL ANALYSIS
Technical Analysis
APGEIRON
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HMVFX15.730.08
+0.51%
Hartford MidCap Value F
MEFAX12.86N/A
N/A
MassMutual Mid Cap Growth A
ICMBX13.54N/A
N/A
Intrepid Capital Investor
RISAX27.85N/A
N/A
Manning & Napier Rainier Intl Discv S
GGIPX23.21N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps P

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with RVMD. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.10%
RVMD - IRON
55%
Loosely correlated
+2.07%
KMSTF - IRON
54%
Loosely correlated
N/A
XNCR - IRON
52%
Loosely correlated
+2.62%
IDYA - IRON
52%
Loosely correlated
+1.08%
SYRE - IRON
52%
Loosely correlated
-1.07%
More